Shares Bazaar

Gujarat Ambuja Exports gains on beginning commercial production at Maltodextrin facility in Karnataka

With this, the company’s total installed capacity for production of Maltodextrin at Hubli, Karnataka has been increased from 7,000 MTPA to 23,000 MTPA

Gujarat Ambuja Exports is currently trading at Rs. 135.35, up by 1.35 points or 1.01% from its previous closing of Rs. 134.00 on the BSE.

The scrip opened at Rs. 133.00 and has touched a high and low of Rs. 136.90 and Rs. 130.70 respectively. So far 7634 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 149.45 on 23-Feb-2026 and a 52 week low of Rs. 101.40 on 15-Oct-2025.

Last one week high and low of the scrip stood at Rs. 136.90 and Rs. 127.20 respectively. The current market cap of the company is Rs. 6231.04 crore.

The promoters holding in the company stood at 63.84%, while Institutions and Non-Institutions held 2.18% and 33.97% respectively.

Gujarat Ambuja Exports has commenced commercial production at its new Maltodextrin facility located at its existing manufacturing unit in Hubli, Karnataka, with effect from March 28, 2026. With the commencement of commercial production at the said facility, the company’s total installed capacity for production of Maltodextrin at Hubli, Karnataka has been increased from 7,000 MTPA to 23,000 MTPA.

Gujarat Ambuja Exports (GAEL) is principally involved in the Agro-processing business with dominance in Maize products and Edible oils.